Karen Seibert

Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

V. Steele, K. Seibert, G. Kelloff, 2000, Cancer research.

The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.

K. Seibert, G. Kelloff, R. Lubet, 2000, Cancer research.

Aspirin-like molecules that covalently inactivate cyclooxygenase-2.

L. Marnett, A. Kalgutkar, K. Seibert, 1998, Science.

Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model.

K. Seibert, H. Abou-Issa, R. Harris, 2000, Oncology reports.

Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.

V. Steele, K. Seibert, G. Kelloff, 2000, Cancer research.